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Splanchnic erythrocyte content decreases during hemodialysis: A new
compensatory mechanism for hypovolemia. Splanchnic and splenic esyth-
rocyte volumes decrease during postural changes and exercise to help
maintain central blood volume and cardiac output. The contribution of
this compensatory mechanism to hemodynamic stability during dialysis
has not been studied, however. In 8 ESRD patients, age 51.0 4.5 years
old, we measured changes in the splanchnic/splenic erythrocyte volume
during dialysis by tagging the patients' erythrocytes with technetium and
following abdominal radioactivity over time. Splanchnic radioactivity
decreased to 90.2 3.8% (mean SCM) of the baseline value after 2 hr
of accelerated fluid removal (3.7 0.4 liters) during dialysis (DUF), while
it remained relatively unchanged after two hours of dialysis without fluid
removal (DD) [106.5 2.3%, P (DUF vs. DD) = 0.03]. Splenic
radioactivity decreased to 89.2 5.0% of the initial value during DUF
versus 103 3.8% during DD, but the decrease was noted only during the
last 30 minutes of DUF and did not attain statistical significance.
Autonomic nervous system integrity was measured by the spontaneous
variation of the R-R interval during deep respiration (Eli ratio) and by the
Valsalva ratio. The mean E/I and Valsalva ratios in the eight patients were
1.13 0.03 (± SCM) and 1.42 0.1 respectively, suggesting reasonably
adequate autonomic nervous system functioning. The results suggest that
contraction of the splanchnic, and possibly the splenic, vascular beds
occurs during fluid removal associated with hemodialysis. The resultant
addition of erythrocytes to the circulation may help maintain central blood
volume and cardiac output.
The hemodynamic causes of hypotension during dialysis are
multifactorial. Compensatory responses to acute hypovolemia
include mechanisms that decrease venous capacity, mechanisms
that increase cardiac contractility and rate, and mechanisms that
increase vascular resistance [1]. A substantial percentage of the
total blood volume is located in the venous system, the capacity of
which can change markedly [2]. Translocation of this blood
volume centrally during hypovolemia can result in a relative
increase in the rate of venous return [31.
The splanchnic/splenic vascular bed is composed of the circu-
lation to the spleen, liver and intestines. It is well established that
splanchnic/splenic capacity decreases during hypovolemia [4—6].
Splanchnic veins are extensively innervated with both alpha- and
beta-adrenergic fibers. Reduction in splanchnic/splenic capacity
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during hypovolemia can be due either to reduced inflow or to
active venoconstriction. Early reductions in splanchnic capacity
may take place due simply to reduced inflow (De Jager-Krogh
effect), whereas increases in plasma epinephrine levels during
severe hypovolemia might act to further reduce splanchnic capac-
ity [7, 8].
As there was no information about changes in splanchnic/
splenic capacity during hemodialysis, we undertook a study to
examine the changes in the splanchnic/splenic erythrocyte blood
volume while fluid was being removed during dialysis as compared
to when no fluid was removed during dialysis. We also studied the
integrity of the autonomic nervous system in the patients that
underwent splanchnic blood pool monitoring, as we anticipated
that changes in splanchnic/splenic capacity might be impaired in
patients with autonomic nervous system (ANS) dysfunction. How-
ever, patients selected for this study were not expected to have
ANS dysfunction.
Methods
Dialysis study
Patients were selected from among those undergoing chronic
hemodialysis at our medical center. Eight patients were studied.
Informed consent was obtained and the protocol was approved by
the Hines VAMC Human Investigations Subcommittee. All pa-
tients were male, with an average age of 51.0 4.5 years. The
patients selected for this study were specifically selected to be
normal controls, that is, none were diabetic, and none were
hypotension prone. The mean dry weight was 76.4 19 kg.
Almost all were using a blood flow rate of 350 mI/mm, and all had
an AV access. Anti-hypertensive medicines were being taken by 4
of the patients (3 CCBs, one ACE inhibitors). These medications
were held the day of the study.
Each patient was studied twice. On one occasion, fluid removal
was accelerated during the initial two hours of dialysis, and zero
during the last two hours. On another occasion, diffusion dialysis
was performed during the initial two hours, and with accelerated
fluid removal during the last two hours. The order of these two
treatments was randomized.
Blood was drawn before dialysis and the erythrocytes in the
sample were tagged with technetium using sterile technique. The
blood was then re-injected into the patient. After equilibration,
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with the patient supine on an examination table, baseline poste-
rior and anterior images of the abdomen were obtained by gamma
camera to assess the radioactivity of the area concerned. This was
followed by extracorporeal circulation (no dialysate flow, no fluid
removal, patient remaining supine) for 30 minutes. A second set
of images was then obtained. Then, the patient, based on ran-
domization assignment, received two hours of either dialytic
ultrafiltration (dialysis with fluid removal) or diffusion dialysis
(dialysis without fluid removal), both given with the patient on the
examining table in the supine position. When fluid was removed,
the total amount of required fluid removal (initial weight less "dry
weight") was performed during the initial two hour period.
Posterior and anterior images were obtained every 30 minutes
during the two-hour study period. Blood samples were also taken
every 30 minutes for hematocrit and measurement of blood
radioactivity. At the end of the two-hour study period, an addi-
tional two hours of dialysis was performed. When no fluid removal
had been removed during the initial two hours, the required
amount of fluid removal was performed during the second
two-hour period. When fluid was removed during the initial two
hours, no fluid was removed during the second two-hour period.
The dialysis treatments were performed with the patients' usual
dialyzers, such as hemophan (HG400) or cuprophan (SCE135).
Bicarbonate dialysis solutions was used for all treatments. It
contained (in mM): sodium 140, calcium 1.75, magnesium 0.5,
potassium 2.0 or 3.0, bicarbonate 40, and dextrose 11.1. Dialysate
flow rate was 500 mI/mm. The patient's usual blood flow rate
(between 300 ml/min to 400 mi/mm) was used for all treatments.
Radionuclide studies
Red blood cells were labeled in vivo using stannous pyrophos-
phate followed by 20 to 25 mCi of technetium-99m pertechnetate.
Images were obtained using a low energy scintillation camera
interfaced to a computer. A region of interest (ROl) was drawn to
include the spleen and a background region medial to the spleen
that avoided major organs and vascular pools. The splanchnic
ROl included the entire region from the diaphragm to the
bifurcation of the abdominal aorta, excluding the spleen and liver.
All ROT counts were corrected for radioactivity decay.
Blood samples for blood and plasma radioactivity were drawn
from a site other than that used for isotope injection. Radioactiv-
ity in 0.25 ml aliquots of blood and plasma was determined using
a gamma counter. At the end of two hours and four hours of
dialysis, after mixing, three samples of dialysate were obtained for
counting for radioactivity. In the data analysis, all initial values
were taken at the point 30 minutes after hooking up to the
dialyzer, after extracorporeal circulation without fluid removal.
Initial blood volume was computed from an anthropometric
equation: BV = 1993 + 39.8 X W, where W was the patient's dry
weight in kg [9]. The estimated initial total Tc content was
obtained by multiplying specific activity of the t30 blood sample
times the estimated initial blood volume. The estimated final total
Tc content was obtained by first computing the t150 blood
volume, as the initial BV x the ratio of the initial to final
hematocrits. The final BV was then multiplied by the t150 specific
activity to obtain final total Tc content. The percent removed was
then computed as 100 x (initial content — final content)/initial
content. The percent removed was also computed from the
dialysate side. The dialysate specific activity was multiplied by 60
liters, and the total Tc removed was subtracted from the estimated
Table 1. Baseline values at 0 and 30 minutes (mean SEM)
DUF
0 mina 30 mi&'
DD
0 min' 30 mind
MAP mm JIg
HR beats/mm
Pre-dialysis weight
gain
108.7 5.7
81.4 3.0
3.7 0.4
110.7 4.4
80.8 3.4
—
108.8 7.9
84.1 3.4
3.4 0.5
108.2 8.7
81.1 3.4
—
P for a vs. b, a vs. c, and b vs. d and c vs. d were non-significant.
initial Tc content. When blood samples were taken for counting,
both whole blood and plasma samples were counted. From the
average plasma level during dialysis and the total amount re-
moved in the dialysate, a plasma Tc clearance was calculated.
Autonomic nervous system testing
Autonomic nervous system testing focused primarily on cardiac
parasympathetic activity, as measured by the spontaneous varia-
tion of the R-R interval during deep respiration and by the
Valsalva ratio as outlined in a prior study [10]. After 10 minutes
in the supine position, a constant ECG was recorded during a
deep breathing procedure for one minute: 5 maximal expirations
and 5 inspirations per minute, using six second inhale and six
second exhale periods. The ElI ratio was calculated from the
mean values of the longest R-R interval during expiration (E) and
the shortest R-R interval during inspiration (I).
After another 10 minutes of rest, the subject performed a
Valsalva maneuver by blowing through a mouth-piece attached to
a manometer and maintaining a pressure of 40 mm Hg for 15
seconds. The test was performed three times during continuous
ECG recording. Between each blowing, the subject rested for
three minutes. The Valsalva ratio was calculated as the mean
longest R-R interval after the maneuvers to the mean shortest
during the maneuvers from 3 ECG recordings. The deep breath-
ing test and Valsalva maneuvers were also performed in 5 healthy
volunteers (age range 25 to 45 years).
Statistical methods and analysis of results
Statistical analysis was performed using the SPSS Statistical
Package for the Social Sciences (SPSS, Inc., Chicago, IL, USA)
PC computer software package. All the data at different time
points were expressed as the percentage change from baseline. As
there were multiple time points for each treatment, a two-factor
(time x treatment) repeated measures analysis of variance design
was used. If a treatment or a time X treatment effect was found,
then the treatment effect at each time point was further explored
by paired t-testing of that time point versus baseline.
Results
Both dialysis treatments were well tolerated without symptom-
atic hypotension. The baseline hemodynamic measurements at 0
minutes and 30 minutes are listed in Table 1. There were no
significant differences in any of these baseline values immediately
prior to DUF versus DD.
By two-factor repeated measures ANOVA, time and treatment
effects were significant for splanchnic erythrocyte content, hemat-
ocrit, and blood radioactivity. Significant treatment-time interac-
tions were seen with splanchnic erythrocyte content and MAP.
Analysis of the individual time points indicated that splanchnic
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Fig. I. Changes in baseline splanchnic eiythrocyte radioactivity over time
during the 2 hr study period. Symbols are: (U) dialysis plus fluid removal
(dialytic ultrafiltration, DUF); (A) dialysis without fluid removal (diffusion
dialysis, DD). Fluid was not removed and dialysate was not circulated
during the initial 30-minute period, marked EC (extracorporeal circula-
tion) on the graph. Asterisks represent a P value < 0.05.
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erythrocyte content decreased significantly during dialytic ultra-
filtration (DUF, Fig. 1). At the same time points, no changes in
the splanchnic erythrocyte content during diffusional dialysis
(DD) were observed. Splenic erythrocyte content remained un-
changed in both DUF and DD during the initial 60 minutes (Fig.
2). Splenic radioactivity decreased when the blood pressure
started to drop during the second hour of DUF, although the
reduction of both the radioactivity of the spleen and MAP did not
reach statistical significance.
There was no significant difference in iriterdialysis weight gain
prior to the study (DUF) compared to the control (DD) sessions:
3.7 0.4 kg versus 3.4 0.5 kg, P = 0.67. Mean arterial pressure
(MAP) remained relatively unchanged during the first 90 minutes
of DUF and then it decreased to 91.2 6.1% (mean SEM; Fig.
3) of the baseline value in the last 30 minutes. MAP remained
unchanged throughout DD. There were no changes in heart rate
during DUF or DD (Fig. 4).
Radioactivity per unit volume of the whole blood increased by
an average of 9.2 10.5% during DUF while it decreased by
9.6 4.6% during DD. The decrease in specific activity with DD
was due to loss of technetium to the dialysate by diffusion during
dialysis. During DUF, the loss of the radioactivity was compen-
sated by hemoconcentration (hematocrit increased by 14.4%
during DUF while it decreased by 0.64% (P = NS) during DD.
The radioactivity of the plasma was about 3 to 4% of that of whole
blood and this proportion did not change over the duration of the
dialysis treatment. Plasma Tc counts were unchanged during
DUF, but fell significantly, by 18 15% during DD (Table 2).
The reason for the lack of decrease in plasma counts during DUF
was unclear. It may have been related to a higher proportion of
red cells in the blood, with a higher equilibrating mass of Tc
associated with erythrocytes.
To assess mass balance and Tc removal, the computations
described in the methods section were done. These results are
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Fig. 3. Change in mean arterial pressure during dialytic ultrafiltration (DUF,
U) and diffusion dialysis (DD, A). There were no significant differences,
although there was a strong trend for a decrease in MAP during the last
30 minutes of DUF.
8
6
U)4
0
—4
—6
—8
0 30
0—EC—0 60 90Time, minutes
120 150
60 90 120 150
Time, minutes
Fig. 4. As shown, there were no sign ifi cant changes in heart rate with either
dialytic ultrafiltration (DUF, U) or diffusion dialysis (DD, A).
Fig. 2. Same graph in Figure 1, except that the region of interest was the
spleen. In contrast to total splanchnic radioactivity (Fig. 1), splenic
radioactivity began to decrease only late during dialytic ultrafiltration(DUF, squares), and the decrease failed to quite reach the 0.05 level of
statistical significance. Symbols are: (U) DUF; (A) DD.
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Table 2. Blood and dialysate technetium counts during dialytic
ultrafitration (DUF) and diffusion dialysis (DD) (mean SD)
Post-dialysis P
DUF-hematocrit % 31.9 5.0 36.6 6.7 0.008
DD-hematocrit % 32.6 5.2 32.5 5.3 NS
DUF-blood Tc counts X 106/ml 2.52 0.68 2.74 0.71 0.004
DD-blood Tc counts >< 106/ml 2.52 1.4 2.24 1.2 0.003
DUF-plasma Tc counts >< 104/ml 9.68 2.1 9.70 1.8 NS
DD-plasma Tc counts X 10!ml 10.6 5.7 8.6 4.5 0.049
DUF-blood volume ml 5032 766 4411 587 0.008
DD-blood volume ml 5032 766 5056 677 NS
DUF-total Tc blood X i0 1.25 0.33 1.19 0.33 NS (0.065)
DD-Total Tc blood X 10l 1.26 0.67 1.12 0.59 0.007
presented in Table 3. It can be seen that, by both blood and
dialysate side methods, the removal of Tc was about 6% over a
two hour period, and this did not differ significantly during the
DUF and DD sessions. The plasma Tc clearance was about 60
mI/mm. Four-hour Tc removal and clearances gave quite consis-
tent results, with an average of 12% of initial Tc content being
removed over a four hours period.
The expiratory/inspiratory (ElI) and Valsalva heart rate ratios
of the eight patients studied were 1.13 0.03 and 1.42 0.1,
respectively. These values are considered within the normal range,
although they were somewhat lower than in the non-uremic
healthy controls.
Discussion
Dialysis hypotension is an important clinical problem. In the
course of an "average" hemodialysis, 2 to 4 liters of ultrafiltrate
must be removed, representing a volume close that of the plasma.
Although such rapid fluid removal can often be achieved without
hypotension, in a substantial percentage of dialysis patients intra-
dialytic hypotension does occur. The causes of hemodialysis
hypotension are multifactorial, and the hemodynamic mecha-
nisms are likewise varied [1].
During acute hypovolemia, several mechanisms are involved to
maintain cardiac output and thus hemodynamic stability. A
substantial percentage of the total blood volume is located in the
venous system. During acute hypovolemia, venous capacity will
decrease to help to maintain cardiac filling [2, 3]. The splanchnie
circulation is one of the most important vascular beds that
participate in maintaining hemodynamic stability. Although the
relative contributions of spleen, liver and intestines to splanehnic-
mediated volume redistribution are not known, the decrease of
splanchnic capacity during hypovolemia in other clinical condi-
tions are well known 14—61. The human spleen can contract on
change to upright posture and during exercise, with the addition
of previously sequestered erythrocytes to the circulation [11].
Our results suggest that splanchnic blood volume did indeed
decrease during dialysis, but only when fluid was removed. The
extent of the reduction in splanchnic red cell radioactivity was on
the order of 10%. This splanchnic erythrocyte shift began during
the first 30 minutes of dialytic ultrafiltration and persisted
throughout the study (Fig. 1). With more fluid removal and a
progressive drop in blood pressure (Fig. 3), our data suggest that
contraction of the spleen may also have occurred (Fig. 2),
Table 3. Technetium removal measures
DUF DD P
2 Hour values
Total Tc dialysate X 10° 0.065 0.023 0.066 0.30 NS
% Removed (blood initial — 4.4 4.4 8.8 6.8 NS (0.084)
final)
% Removed (initial 5.9 1.9 6.2 1.2 NS
dialysate)linitial
Plasma cleared of Tc in 2 6994 2731 7370 1241 NS
hours (ml)
Clearance (plasma cleared! 58 23 61 10 NS
120)
4 Hour values
Total Tc dialysate X 10° 0.12 0.043 0.14 0.59 NS
% Removed (initial 11.4 3.9 13.0 12.7 NS
dialysate)!initial
although this finding needs to be interpreted cautiously, as the
reduction in splenic radioactivity did not quite attain statistical
significance.
The reduction in splanchnic radioisotope count observed dur-
ing DUF was not due to loss of radioactivity by decay, as decay
was accounted for in the computations. The reduction was not due
to diffusional loss of radioactivity during dialysis, as the splanchnic
erythrocyte content decreased significantly only during dialytic
fluid removal and not during dialysis without fluid removal.
During dialysis with or without fluid removal, some radioactivity
of the peripheral blood was lost as a result of diffusion of the
radioisotope to the dialysate. This was indicated by the decrease
in the peripheral blood radioactivity count during the diffusional
dialysis without fluid removal (Table 2). With DUF, of course, the
peripheral blood radioactivity count increased (Table 2) as a
result of the increase in hematocrit that occurred. The fact that
overall Tc loss was consistent whether measured from the blood
or dialysate side provides evidence that at 30 minutes, equilibra-
tion of Tc was relatively complete. If it had not been, one would
have expected the percent Tc removed computed based on pre-
and post-specific activities and hematocrits to be greater than
percent Tc removed computed based on dialysate recovery. Such
a discrepancy was not found, however.
Plasma Tc counts decreased by about 18% during DD, but were
unchanged during DUF. Why this was so is not immediately
apparent. Perhaps the increase in Hct during DUF caused more
transfer of Tc from erythrocytes to plasma during DUF, increas-
ing the plasma counts slightly. As plasma Tc counts were only 4%
that of whole blood, any minor change in erythrocyte to plasma Te
transfer rate could account for marked changes in the plasma
level. Tc removal was similar during DD and DUF, whereas one
might have predicted increased removal during DUF due to
convective transport. Again, as the total removal of Tc was only
about 6% of the injected dose, small differences in Tc removal
between DD and DUF could not be detected with the sample size
used.
Evidence of hemodynamic changes during hemodialysis as a
result of peripheral pooling of the blood was first provided by
Chen et al [12]. The ratio of end-diastolic cardiac volume to total
blood volume (EDV/TBV) was taken to be a measure of periph-
eral pooling. An increased EDV/TBV ratio would reflect a central
shift of the blood volume whereas a decreased EDVITBV ratio
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would signal peripheral pooling. During regular acetate hemodi-
alysis, EDV/TBV decreased, presumably due to venodilation and
peripheral pooling, whereas during bicarbonate dialysis EDV/
TBW increased, suggesting a central shift of the blood volume [12,
13]. It would be of interest to compare splanchnic volume shifts
during bicarbonate versus acetate dialysis. As acetate causes
selective splanchnic vasodilatation [14], it is possible that the
peripheral pooling of blood noted by Chen et al may have been
due to splanchnic sequestration of erythrocytes via a reverse
DeJager-Krogh effect. Another area of interest to explore might
be whether or not the hemodynamic benefits of isolated ultrafil-
tration or cool dialysate are partly mediated via enhanced mobi-
lization of splanchnic erythrocytes.
One approach to the study of autonomic reflexes in patients is
to focus primarily on cardiac parasympathetic activity, as mea-
sured by the spontaneous variation of the R-R interval during
deep respiration and by the Valsalva ratio [101. These tests have
been proven to be a sensitive test of autonomic neuropathy in
early diabetes [15-.17]. This method is quite sensitive and repro-
ducible for detecting autonomic nervous system defects. A Val-
salva ratio of 1.25 or less or R-R variation with E/I ratio less than
1.05 is associated with autonomic neuropathy [10]. In the patients
we studied, the autonomic reflexes controlling heart rate ap-
peared to be relatively intact, with a mean Valsalva ratio of 1.43
and ElI ratio of 1.13. It is possible that their intact autonomic
reflexes were required to effect a reduction in splanchnic vascular
bed volume during dialysis.
The question remains: what about patients in whom the ANS is
clearly impaired? Originally, we planned to identify and study
patients with clearly impaired ANS function and assess their
splanchnic volume changes during dialysis. We did manage to
study one such patient, in whom the Valsalva and E/i ratios were
close to unity. In this patient there was no evidence of a decrease
in either splanchnic or splenic radioactivity during DUF, despite a
considerable fall in MAP. Further study was made impossible,
however, due to a change of mission of the hospital where these
investigations were performed (outsourcing of dialysis). So the
investigation of the relation between ANS dysfunction and
splanchnic volume changes during dialysis remains an area for
further investigation.
In summary, our results suggest that translocation of erythro-
cytes from the splanchnic circulation (and possibly from the
spleen) may be one of the mechanisms whereby the body com-
pensates for hypovolemic stress during dialytic ultrafiltration. This
mechanism was demonstrated to occur in dialysis patients with a
relatively intact autonomic nervous system. Whether patients with
ANS dysfunction can also reduce splanchnic erythrocyte volume
during dialysis remains a topic that requires further study. Other
areas to explore are the effects of isolated ultrafiltration or cool
dialysate on splanchnic volume during ultrafiltration.
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